Bridgeway Capital Management’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$381K Sell
110,800
-14,200
-11% -$48.8K 0.01% 818
2025
Q1
$266K Buy
+125,000
New +$266K 0.01% 860
2024
Q3
Sell
-13,400
Closed -$134K 1267
2024
Q2
$134K Sell
13,400
-5,000
-27% -$49.9K ﹤0.01% 1132
2024
Q1
$219K Hold
18,400
﹤0.01% 1095
2023
Q4
$74K Hold
18,400
﹤0.01% 1282
2023
Q3
$50.4K Hold
18,400
﹤0.01% 1303
2023
Q2
$123K Hold
18,400
﹤0.01% 1226
2023
Q1
$117K Hold
18,400
﹤0.01% 1205
2022
Q4
$45.5K Hold
18,400
﹤0.01% 1306
2022
Q3
$42K Hold
18,400
﹤0.01% 1360
2022
Q2
$57K Hold
18,400
﹤0.01% 1274
2022
Q1
$67K Hold
18,400
﹤0.01% 1282
2021
Q4
$71K Sell
18,400
-9,000
-33% -$34.7K ﹤0.01% 1234
2021
Q3
$173K Hold
27,400
﹤0.01% 1214
2021
Q2
$219K Sell
27,400
-26,000
-49% -$208K ﹤0.01% 1249
2021
Q1
$582K Buy
53,400
+35,000
+190% +$381K 0.01% 1052
2020
Q4
$83K Sell
18,400
-10,000
-35% -$45.1K ﹤0.01% 1278
2020
Q3
$166K Hold
28,400
﹤0.01% 1196
2020
Q2
$158K Buy
+28,400
New +$158K ﹤0.01% 1181
2019
Q2
Sell
-16,870
Closed -$62K 1323
2019
Q1
$62K Hold
16,870
﹤0.01% 1304
2018
Q4
$51K Sell
16,870
-980
-5% -$2.96K ﹤0.01% 1336
2018
Q3
$93K Hold
17,850
﹤0.01% 1386
2018
Q2
$80K Hold
17,850
﹤0.01% 1377
2018
Q1
$75K Sell
17,850
-5,000
-22% -$21K ﹤0.01% 1343
2017
Q4
$91K Hold
22,850
﹤0.01% 1344
2017
Q3
$118K Hold
22,850
﹤0.01% 1328
2017
Q2
$143K Hold
22,850
﹤0.01% 1328
2017
Q1
$135K Hold
22,850
﹤0.01% 1317
2016
Q4
$133K Sell
22,850
-4,660
-17% -$27.1K ﹤0.01% 1348
2016
Q3
$198K Hold
27,510
﹤0.01% 1323
2016
Q2
$239K Hold
27,510
﹤0.01% 1269
2016
Q1
$248K Hold
27,510
﹤0.01% 1261
2015
Q4
$258K Buy
27,510
+6,030
+28% +$56.6K ﹤0.01% 1246
2015
Q3
$301K Buy
21,480
+5,000
+30% +$70.1K 0.01% 1216
2015
Q2
$244K Buy
16,480
+500
+3% +$7.4K ﹤0.01% 1310
2015
Q1
$251K Buy
15,980
+980
+7% +$15.4K 0.01% 1291
2014
Q4
$219K Buy
+15,000
New +$219K 0.01% 1285